Why did this ASX cannabis share burn 10% today?

Creso Pharma has announced a capital raise. Here are the details.

| More on:
Man in a cannabis greenhouse looks unhappy and puts his thumb down.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Shares in ASX-listed cannabis company Creso Pharma are plummeting today on news of a capital raise
  • The company is raising $5 million through a placement
  • The raised funds will go towards its expansion into the United States, as well as other ventures

The Creso Pharma Ltd (ASX: CPH) share price was far from green on Friday after the ASX cannabis company broke a multi-day trading halt with news of a capital raise.

Creso Pharma is raising $5 million through a placement wherein it will offer new shares for 6.9 cents apiece.

At the close of trading, the Creso Pharma share price was 6.9 cents, having tumbled 10.39%.

Let's take a look at what the ASX cannabis share plans to do with its raised cash.

What sent this ASX cannabis share plummeting?

ASX cannabis company Creso Pharma's share price is falling after the company announced a placement to raise $5 million to help fund its expansion into the United States.

As part of the placement, involved investors will receive 1 free option for every share they purchase.

On top of that, the placement's broker, EverBlu Capital, will also receive an option for every free option handed out.

The options will be exercisable at a price of 14 cents each on or before the 18-month anniversary of their issuing.

Creso Pharma non-executive director Adam Blumenthal has committed to purchasing around $318,250 worth of new shares as part of the placement. Blumenthal's participation is subject to shareholder approval at a future general meeting.

The $5 million will be put towards the company's expansion into the United States after it acquires Sierra Sage Herbs and Green Goo brand.

The cannabis company announced its acquisition to the ASX earlier this month, causing its share price to surge 5.8%.

Some of the funds raised through the placement will go towards product development and general working capital.

Speaking on the capital raise, Creso Pharma CEO and managing director, William Lay commented:

These funds will provide us with additional financial flexibility to advance our US-focused growth trajectory, progress a number of new product development initiatives, and explore new opportunities to unlock shareholder value.

The company remains very well positioned to capitalise on the global market for recreational cannabis, CBD products, and psychedelic treatments. We have a number of growth initiatives underway and look forward to providing additional updates as these materialise.

Creso Pharma share price snapshot

This year so far has been rough on the Creso Pharma share price.

It has fallen 15% since the start of the year. It's also 60% lower than it was this time last year.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Cannabis Shares

Man in a cannabis greenhouse looks unhappy and puts his thumb down.
Cannabis Shares

Why are these 2 ASX cannabis stocks sputtering today?

Up 174% in 2023, this ASX cannabis share is giving back some more of its gains today.

Read more »

A young male investor wearing a white business shirt screams in frustration with his hands grasping his hair after ASX 200 shares fell rapidly today and appear to be heading into a stock market crash
Cannabis Shares

Guess which ASX cannabis share is crashing 36% following an FDA blow

Rookie mistake: This cannabis share just missed out on FDA approval for a simple reason.

Read more »

A Cronos Australia farmer and ASX cannabis shares investor stands in a field of cannabis plants and smiles at the camera
Cannabis Shares

Could ASX cannabis shares be set for a resurgence?

The world's legal and medical fraternities are taking small steps forward in the medicinal cannabis movement.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Cannabis Shares

This ASX cannabis stock is up 160% since June, and it has an FDA ruling coming up!

Investors are very excited about this cannabis stock.

Read more »

two men in formal business clothing closely inspect a bud from a cannabis crop.
Cannabis Shares

Why ASX cannabis shares just jumped back into the spotlight

ASX cannabis shares operate in a nation where medical marijuana is legal but recreational use remains broadly forbidden.

Read more »

A hip young man with a beard and manbun sits thoughtfully at his laptop computer in a darkened room, staring at the screen with his chin resting on his hand in thought.
Cannabis Shares

Should I buy Incannex shares while they're at multi-year lows, or steer clear?

Is the cannabis-based pharma company a bargain buy right now?

Read more »

Man in the green house growing medical cannabis
Cannabis Shares

A $3k investment in ASX cannabis stock Incannex 5 years ago is now worth $15,000. Here's why

This medicinal cannabis company has been a rare winner in its field.

Read more »

a man wearing old fashioned aviator cap and goggles emerges from the top of a cannon pointed towards the sky. He is holding a phone and taking a selfie.
Cannabis Shares

Which ASX cannabis share is surging 27% on record quarterly results?

Althea CEO Josh Fegan has declared "a landmark turning point" for the company.

Read more »